Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07138729Not ApplicableRecruiting

Research on the Application of 99mTc-TCR-FAPI SPECT Imaging in Rheumatoid Arthritis

Role: lead

NCT07138716Not ApplicableRecruiting

Research on the Application of 68Ga-DOTA-CCK-FS PET/CT in MTC

Role: lead

NCT07104058Not ApplicableRecruiting

A Study on the Effect of MRD Detected by FAPI PET / CT on the Recurrence of IgG4-RD

Role: lead

NCT06973798Not ApplicableNot Yet Recruiting

The Study on the Effectiveness of [68Ga]Ga-HBED-CC-DiAsp PET/CT in Calculating GFR and Predicting Residual Renal Function After Partial Nephrectomy

Role: lead

All 4 trials loaded